Cite
HARVARD Citation
Palmieri, L. et al. (2020). Withholding the Introduction of Anti‐Epidermal Growth Factor Receptor: Impact on Outcomes in RAS Wild‐Type Metastatic Colorectal Tumors: A Multicenter AGEO Study (the WAIT or ACT Study). Oncologist. pp. e266-e275. [Online].